Schroders beats sector competitors in new standards first
The asset management group, which had £98.9bn of funds under management at December 31 last year, is expected to reveal its converted accounts on November 23, one week after releasing its trading statement.
Jonathan Asquith, chief finance officer at Schroders, is following in the footsteps of pharmaceutical giants AstraZeneca and GlaxoSmithKline which have already restated their accounts under the new standards.
Asquith, who previously worked for Deutsche Asset Management and Morgan Grenfell, was appointed as Schroders chief finance officer in March 2002.
To read the rest of the article you'll need to log in below
If you've forgotten your details click here for a reminder.
If you haven't got an account, it's free and it only takes a minute to set one up,
click here to register